Clinical Trial Update: Vaginal Misoprostol Versus Bilateral Uterine Artery Ligation in Decreasing Blood Loss in Trans-abdominal Myomectomy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vaginal misoprostol with bilateral uterine artery ligation to reduce blood loss during trans-abdominal myomectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Cytotec (misoprostol) (misoprostol)
• Uterine artery ligation

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Vaginal Misoprostol and Bilateral Uterine Artery Ligation in Decreasing Blood Loss in Trans-abdominal Myomectomy | Phase 4 | Status: UNKNOWN